Aarti Drugs informed that its Baddi facility has received Establishment Inspection Report (EIR) from US drug regulator, concluding the inspection as closed.

Aarti Drugs Baddi unit gets EIR from USFDA

Buzzing Stocks Today, Stocks that will see action today: July 30, 2024 - India Cements, CESC, Tata Steel, RITES, Oberoi Realty, Bharti Airtel, SIS, Aarti Drugs, ITD Cementation, Sona BLW, PNB Housing

Stocks that will see action today: July 30, 2024

The US FDA had conducted an inspection at the manufacturing facility on April 23.

Aarti Drugs’ Subsidiary Gets Establishment Inspection Report From US FDA

Aarti Drugs Q1 Results | बिजनेस आउटलुक पर कंपनी  के CFO, Adish Patil से खास बातचीत

Aarti Drugs consolidated net profit declines 30.53% in the June 2024 quarter

Companies like Aarti Drugs, Amber Enterprises, Bandhan Bank, Cholamandalam Investment, City Union Bank, ESAF SFB, Equitas SFB, Mangalam Organics, Piramal Pharma, TTK Prestige among others will also declare their results.

Q1 results today: IndiGo, IndusInd among 69 companies to announce earnings on Friday

The fire was brought under control immediately, however production operation of the said unit has been temporarily disrupted. There is no loss of life or injuries reported. Adequate steps are being undertaken to restore the operation of the unit.

Aarti Drugs reports fire incident at one of its unit at Tarapur

In the API sector, a positive shift in the export landscape is anticipated in the near future, supported by interest rate reductions, low stock levels, and
an upswing in demand.

Aarti Drugs Q4 Results Review - API Prices Bottomed Out: Axis Securities

FIRST ON ZEE BUSINESS 

आगे मार्जिन में बढ़त संभव : अधीश पाटिल, CFO, Aarti Drugs

नतीजों और सेक्टर आउटलुक पर Aarti Drugs के टॉप मैनेजमेंट से बात

#newsparviews  #aartidrugs  #stockmarket #anilsinghvi #zeebusiness #stockmarket #business 


About Zee Business:

Zee Business is India's Number 1 Hindi business news channel. It's your channel for profit and wealth. Watch Live coverage of Indian markets - Sensex & Nifty, also for expert insights and advise from our team of experts.
 
--------------------------------------------------------------
Subscribe Zee Business: https://bit.ly/3L6GG0C
 
Business की हर बड़ी ख़बर से रहें अपडेट फॉलो करें ZEE Business का WhatsApp चैनल:   https://bit.ly/3RvzK1N

You Can Also Visit Our Website at: 

Zee Business: https://www.zeebiz.com/
Zee News: https://zeenews.india.com/
DNA India:-https://www.dnaindia.com/
WION: https://www.wionews.com/ 

Follow Us On: 
  
Facebook: https://goo.gl/OMJgrn
Twitter: https://goo.gl/OjOzpB 
Download Zee News App : https://bit.ly/ZeeNewsApps

Aarti Drugs CFO Adhish Patil Discusses March Results, Profit Margins and Market Trends

#shorts | Aarti Drugs Shares To Fall Soon? | होल्ड या फिर और खरीदना है Aarti Drugs ? | N18S

#sensex #sharemarket #sharemarketnewstoday #sharemarkettoday #stockmarket #sharebazar #nifty #banknifty #sharemarketindia

n18oc_shorts

Business News | CNBC Awaaz brings to you latest business news, live share market updates, stock market updates, top business news in india, stock market updates, ipo latest updates, news updates on banking and financials, realty sector and it sector. Watch business news live, business news and share market live updates on CNBC Awaaz. Stay tune to get all the news of pre-opening trades, opening trades, and top calls in pehla sauda. Know what market veterans have to say on the current market trends in big market voices. Watch final trade market strategy, btst stbt calls, intraday strategy and brokerage house calls, quarterly results expectations in kamai ka adda with anuj singhal and virendra kumar. Also stay tune to watch share market tomorrow strategy in kal ka bazaar. Watch CNBC Awaaz and get the best investment ideas.  

CNBC Awaaz is one of India’s top business channels and a leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence. 

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz
Website: https://hindi.cnbctv18.com/
Whatsapp Link: http://bit.ly/3RiTpSc

#shorts | Aarti Drugs Shares To Fall Soon? | होल्ड या फिर और खरीदना है Aarti Drugs ? | N18S

Demand slowdown in exports & lower realization impacts API growth.

Aarti Drugs Q3 Results Review - Negative Rate Variance Impacts API Sales: Dolat Capital

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Aarti Drugs Limited is a pharmaceutical company  offering active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins.

Aarti Drugs Ltd

Aarti Drugs Ltd

Scorecard

News & Opinions